Agata M. Bogusz

761 total citations
25 papers, 480 citations indexed

About

Agata M. Bogusz is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Agata M. Bogusz has authored 25 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 11 papers in Oncology and 7 papers in Genetics. Recurrent topics in Agata M. Bogusz's work include Lymphoma Diagnosis and Treatment (12 papers), Cutaneous lymphoproliferative disorders research (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Agata M. Bogusz is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Cutaneous lymphoproliferative disorders research (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Agata M. Bogusz collaborates with scholars based in United States, France and United Kingdom. Agata M. Bogusz's co-authors include Adam Bagg, Scott J. Rodig, Jeffery L. Kutok, Suzanne D. Conzen, Deanna R. Brickley, Weina Chen, Raheela Ashfaq, Rolando García, Adam C. Seegmiller and Ping Shang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Agata M. Bogusz

25 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Agata M. Bogusz United States 13 240 204 152 110 71 25 480
Julie C. Porcher United States 8 213 0.9× 126 0.6× 106 0.7× 71 0.6× 69 1.0× 13 399
Julia Steinhilber Germany 15 392 1.6× 260 1.3× 144 0.9× 235 2.1× 132 1.9× 28 652
Ondřej Havránek Czechia 13 191 0.8× 154 0.8× 240 1.6× 122 1.1× 85 1.2× 45 538
Beata Holkova United States 13 297 1.2× 307 1.5× 222 1.5× 139 1.3× 87 1.2× 48 634
Pierre Brousset France 6 208 0.9× 138 0.7× 196 1.3× 75 0.7× 109 1.5× 7 457
Rachel Swart United States 9 194 0.8× 353 1.7× 191 1.3× 42 0.4× 202 2.8× 11 671
Yoshiaki Chinen Japan 14 134 0.6× 143 0.7× 291 1.9× 58 0.5× 78 1.1× 49 513
Chengfeng Bi China 12 325 1.4× 256 1.3× 162 1.1× 88 0.8× 97 1.4× 29 536
Sophie Gazzo France 16 453 1.9× 247 1.2× 266 1.8× 448 4.1× 121 1.7× 32 856
Yoshikazu Sasaki Japan 11 272 1.1× 184 0.9× 94 0.6× 97 0.9× 79 1.1× 23 491

Countries citing papers authored by Agata M. Bogusz

Since Specialization
Citations

This map shows the geographic impact of Agata M. Bogusz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agata M. Bogusz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agata M. Bogusz more than expected).

Fields of papers citing papers by Agata M. Bogusz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agata M. Bogusz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agata M. Bogusz. The network helps show where Agata M. Bogusz may publish in the future.

Co-authorship network of co-authors of Agata M. Bogusz

This figure shows the co-authorship network connecting the top 25 collaborators of Agata M. Bogusz. A scholar is included among the top collaborators of Agata M. Bogusz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agata M. Bogusz. Agata M. Bogusz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qian, Hong Y. Wang, Selene Nuñez-Cruz, et al.. (2022). Induction of Transcriptional Inhibitor HES1 and the Related Repression of Tumor-Suppressor TXNIP Are Important Components of Cell-Transformation Program Imposed by Oncogenic Kinase NPM-ALK. American Journal Of Pathology. 192(8). 1186–1198. 2 indexed citations
2.
Harrington, Colleen T., Elena Sotillo, Aude Robert, et al.. (2019). Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma. Leukemia. 33(10). 2429–2441. 21 indexed citations
3.
Landsburg, Daniel J., Mitchell E. Hughes, David A. Bond, et al.. (2019). Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy. Blood Advances. 3(2). 132–135. 15 indexed citations
4.
Baraban, Ezra, Sam Sadigh, Jason N. Rosenbaum, et al.. (2019). Cyclin D1 expression and novel mutational findings in Rosai‐Dorfman disease. British Journal of Haematology. 186(6). 837–844. 34 indexed citations
5.
Devins, Kyle M., Stephen J. Schuster, Gabriel C. Caponetti, & Agata M. Bogusz. (2018). Rare case of low-grade extranodal NK/T-cell lymphoma, nasal type, arising in the setting of chronic rhinosinusitis and harboring a novel N-terminal KIT mutation. Diagnostic Pathology. 13(1). 92–92. 3 indexed citations
9.
Bogusz, Agata M. & Adam Bagg. (2016). Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets. Leukemia & lymphoma. 57(9). 1991–2013. 21 indexed citations
10.
Watt, Christopher D., Jennifer J.D. Morrissette, Adam I. Rubin, et al.. (2016). Marginal zone lymphoma-derived interfollicular diffuse large B-cell lymphoma harboring 20q12 chromosomal deletion and missense mutation of BIRC3 gene: a case report. Diagnostic Pathology. 11(1). 137–137. 6 indexed citations
11.
Bogusz, Agata M., et al.. (2016). An Unusual Case of Extranodal Diffuse Large B-Cell Lymphoma Infiltrating Skeletal Muscle: A Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 2016. 1–8. 14 indexed citations
12.
Bogusz, Agata M., et al.. (2013). An Unusual Case of Philadelphia Chromosome–Positive Chronic Myelogenous Leukemia With Trisomy 19 Presenting With Megakaryoblastosis and Myelofibrosis. Archives of Pathology & Laboratory Medicine. 137(8). 1147–1151. 2 indexed citations
13.
Chen, Lin‐Feng, Stefano Monti, Przemysław Juszczyński, et al.. (2013). SYK Inhibition Modulates Distinct PI3K/AKT- Dependent Survival Pathways and Cholesterol Biosynthesis in Diffuse Large B Cell Lymphomas. Cancer Cell. 23(6). 826–838. 130 indexed citations
14.
Bogusz, Agata M., et al.. (2013). Extreme Signet Ring Cell Change in a Large B-Cell Lymphoma of Follicular Origin. International Journal of Surgical Pathology. 21(4). 399–403. 5 indexed citations
15.
Bogusz, Agata M., Richard H. G. Baxter, Treeve Currie, et al.. (2012). Quantitative Immunofluorescence Reveals the Signature of Active B-cell Receptor Signaling in Diffuse Large B-cell Lymphoma. Clinical Cancer Research. 18(22). 6122–6135. 34 indexed citations
16.
Bogusz, Agata M. & Parul Bhargava. (2012). Recurrent Histiocytic Necrotizing Lymphadenitis With a Long Latency in a Patient With Autoimmunity. International Journal of Surgical Pathology. 21(3). 287–296. 14 indexed citations
17.
Bogusz, Agata M.. (2012). [The CIC chloride channels and their role in plant cell].. PubMed. 58(1). 54–60. 1 indexed citations
18.
Bogusz, Agata M., Adam C. Seegmiller, Rolando García, et al.. (2009). Plasmablastic Lymphomas With MYC/IgH Rearrangement. American Journal of Clinical Pathology. 132(4). 597–605. 57 indexed citations
20.
Bogusz, Agata M., Joachim Grötzinger, Andreas Herrler, et al.. (2002). Full-Length Complementary DNA and the Derived Amino Acid Sequence of Horse Uteroglobin1. Biology of Reproduction. 66(6). 1723–1728. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026